Interest Expense of Nu-Med Plus, Inc. from 31 Dec 2011 to 31 Mar 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Nu-Med Plus, Inc. quarterly and annual Interest Expense in USD history and change rate from 31 Dec 2011 to 31 Mar 2024.
  • Nu-Med Plus, Inc. Interest Expense for the quarter ending 31 Mar 2024 was $1,247, a 1.1% increase year-over-year.
  • Nu-Med Plus, Inc. annual Interest Expense for 2022 was $1,000.
  • Nu-Med Plus, Inc. annual Interest Expense for 2020 was $14,322, a 18% decline from 2019.
  • Nu-Med Plus, Inc. annual Interest Expense for 2019 was $17,406.
Source SEC data
View on sec.gov
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Change (%)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Change (%)

Nu-Med Plus, Inc. Quarterly Interest Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $1,247 +$14 +1.1% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q3 2023 $1,260 01 Jul 2023 30 Sep 2023 10-Q 01 Nov 2023 2023 Q3
Q2 2023 $1,247 01 Apr 2023 30 Jun 2023 10-Q 11 Aug 2023 2023 Q2
Q1 2023 $1,233 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024 2024 Q1
Q1 2021 $10,301 $0 -$4,021 -100% 01 Jan 2021 31 Mar 2021 10-Q 17 May 2021 2021 Q1
Q4 2020 $14,322 $2,214 -$19,705 -90% 01 Oct 2020 31 Dec 2020 10-K/A 11 Apr 2022 2021 FY
Q3 2020 $34,027 $4,066 -$297 -6.8% 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021 2021 Q3
Q2 2020 $34,324 $4,021 +$8,420 01 Apr 2020 30 Jun 2020 10-Q 16 Aug 2021 2021 Q2
Q1 2020 $25,904 $4,021 +$8,498 01 Jan 2020 31 Mar 2020 10-Q 17 May 2021 2021 Q1
Q4 2019 $17,406 $21,919 +$26,876 01 Oct 2019 31 Dec 2019 10-K 31 Mar 2021 2020 FY
Q3 2019 $9,470 $4,363 +$9,142 01 Jul 2019 30 Sep 2019 10-Q 16 Nov 2020 2020 Q3
Q2 2019 $18,612 $4,399 +$443 +9.1% 01 Apr 2019 30 Jun 2019 10-Q 19 Aug 2020 2020 Q2
Q1 2019 $19,055 $4,477 +$481 +9.7% 01 Jan 2019 31 Mar 2019 10-Q 14 May 2020 2020 Q1
Q4 2018 $19,536 $4,957 +$42 +0.84% 01 Oct 2018 31 Dec 2018 10-K 30 Mar 2020 2019 FY
Q3 2018 $19,578 $4,779 +$449 +8.6% 01 Jul 2018 30 Sep 2018 10-Q 14 Nov 2019 2019 Q3
Q2 2018 $20,027 $4,842 -$92 -1.9% 01 Apr 2018 30 Jun 2018 10-Q 14 Aug 2019 2019 Q2
Q1 2018 $19,935 $4,958 -$1,055 -27% 01 Jan 2018 31 Mar 2018 10-Q 15 May 2019 2019 Q1
Q4 2017 $18,880 $4,999 -$5,681 -833% 01 Oct 2017 31 Dec 2017 10-K 01 Apr 2019 2018 FY
Q3 2017 $13,199 $5,228 +$331 +6% 01 Jul 2017 30 Sep 2017 10-Q 19 Nov 2018 2018 Q3
Q2 2017 $13,530 $4,750 +$763 +14% 01 Apr 2017 30 Jun 2017 10-Q 02 Aug 2018 2018 Q2
Q1 2017 $14,293 $3,903 +$1,615 +29% 01 Jan 2017 31 Mar 2017 10-Q 11 May 2018 2018 Q1
Q4 2016 $15,908 $682 +$4,691 01 Oct 2016 31 Dec 2016 10-K 03 Apr 2018 2017 FY
Q3 2016 $20,599 $5,559 -$1,549 -39% 01 Jul 2016 30 Sep 2016 10-Q 14 Nov 2017 2017 Q3
Q2 2016 $19,050 $5,513 -$1,547 -39% 01 Apr 2016 30 Jun 2016 10-Q 18 Aug 2017 2017 Q2
Q1 2016 $17,503 $5,518 -$1,595 -41% 01 Jan 2016 31 Mar 2016 10-Q 17 May 2017 2017 Q1
Q4 2015 $15,908 $4,009 $0 0% 01 Oct 2015 31 Dec 2015 10-K 19 Apr 2017 2016 FY
Q3 2015 $15,908 $4,010 $0 0% 01 Jul 2015 30 Sep 2015 10-Q 09 Nov 2016 2016 Q3
Q2 2015 $15,908 $3,966 $0 0% 01 Apr 2015 30 Jun 2015 10-Q 15 Aug 2016 2016 Q2
Q1 2015 $15,908 $3,923 +$30,716 +89% 01 Jan 2015 31 Mar 2015 10-Q 16 May 2016 2016 Q1
Q4 2014 $46,624 $4,009 +$35,387 +90% 01 Oct 2014 31 Dec 2014 10-K 13 Apr 2016 2015 FY
Q3 2014 $82,011 $4,010 +$50,339 +93% 01 Jul 2014 30 Sep 2014 10-Q 23 Nov 2015 2015 Q3
Q2 2014 $132,350 $3,966 -$1,198 -43% 01 Apr 2014 30 Jun 2014 10-Q 12 Aug 2015 2015 Q2
Q1 2014 $131,152 $34,639 -$32,497 -1517% 01 Jan 2014 31 Mar 2014 10-Q 15 May 2015 2015 Q1
Q4 2013 $98,655 $39,396 -$34,861 -769% 01 Oct 2013 31 Dec 2013 10-K 23 Mar 2015 2014 FY
Q3 2013 $63,794 $54,349 -$54,349 01 Jul 2013 30 Sep 2013 10-Q 14 Nov 2014 2014 Q3
Q2 2013 $9,445 $2,768 -$2,768 01 Apr 2013 30 Jun 2013 10-Q 11 Aug 2014 2014 Q2
Q1 2013 $6,677 $2,142 -$2,142 01 Jan 2013 31 Mar 2013 10-Q 13 May 2014 2014 Q1
Q4 2012 $4,535 $4,535 -$4,535 01 Oct 2012 31 Dec 2012 10-K 21 Feb 2014 2013 FY
Q3 2012 $0 $0 01 Jul 2012 30 Sep 2012 10-Q 14 Nov 2013 2013 Q3
Q2 2012 $0 01 Apr 2012 30 Jun 2012 10-Q 13 Aug 2013 2013 Q2
Q1 2012 $0 01 Jan 2012 31 Mar 2012 10-Q 14 May 2013 2013 Q1
Q4 2011 $0 19 Oct 2011 31 Dec 2011 10-K 28 Mar 2013 2012 FY

Nu-Med Plus, Inc. Annual Interest Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2022 $1,000 01 Jan 2022 31 Dec 2022 10-K/A 03 Apr 2023 2022 FY
2020 $14,322 -$3,084 -18% 01 Jan 2020 31 Dec 2020 10-K/A 11 Apr 2022 2021 FY
2019 $17,406 +$36,942 01 Jan 2019 31 Dec 2019 10-K 31 Mar 2021 2020 FY
2018 $19,536 -$656 -3.5% 01 Jan 2018 31 Dec 2018 10-K 30 Mar 2020 2019 FY
2017 $18,880 -$2,972 -19% 01 Jan 2017 31 Dec 2017 10-K 01 Apr 2019 2018 FY
2016 $15,908 $0 0% 01 Jan 2016 31 Dec 2016 10-K 03 Apr 2018 2017 FY
2015 $15,908 +$30,716 +66% 01 Jan 2015 31 Dec 2015 10-K 19 Apr 2017 2016 FY
2014 $46,624 +$52,031 +53% 01 Jan 2014 31 Dec 2014 10-K 13 Apr 2016 2015 FY
2013 $98,655 -$94,120 -2075% 01 Jan 2013 31 Dec 2013 10-K 23 Mar 2015 2014 FY
2012 $4,535 01 Jan 2012 31 Dec 2012 10-K 21 Feb 2014 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.